electroCore Stock Forecast
NASDAQ: ECORHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
Market open · Delayed 15 min · as of Oct 9, 10:24 AM ET
ECOR analyst consensus
Consensus (5 analysts)
none
Avg. price target
$19.17+99.17%
- Strong buy 1
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering electroCore (2026-10-09), 5 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $19.17, with a high estimate of $26.00 and a low estimate of $12.00. The average target implies upside of 99.2% from the current price of $9.63.
The spread between the highest and lowest targets is 116.7%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ECOR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 20% |
| Buy | 4 | 80% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $12.00 | +24.68% |
| Average target | $19.17 | +99.17% |
| High target | $26.00 | +170.13% |